Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age

Women remain at risk of human papillomavirus (HPV) infection for most of their lives. The duration of protection against HPV‐16/18 from prophylactic vaccination remains unknown. We investigated the 10‐year immune response and long‐term safety profile of the HPV‐16/18 AS04‐adjuvanted vaccine (AS04‐HP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Schwarz, Tino F., Galaj, Andrzej, Spaczynski, Marek, Wysocki, Jacek, Kaufmann, Andreas M., Poncelet, Sylviane, Suryakiran, Pemmaraju V., Folschweiller, Nicolas, Thomas, Florence, Lin, Lan, Struyf, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Cancer Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5673947/
https://ncbi.nlm.nih.gov/pubmed/28984053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1155
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados